Pfenex Inc. Awards Glide Pharma Development Contract for a Solid Formulation of Recombinant Anthrax Vaccine
4/30/2013 10:21:06 AM
More...
|
Glide Pharma Appoints Dr Mark Carnegie-Brown as Chief Executive
3/6/2013 1:40:34 PM
More...
|
Glide Pharma Announces Completion of $21.4 Million Investment
2/26/2013 7:15:10 AM
More...
|
Glide Pharma Announces £2.3 Million ($3.7 Million) Award From UK Biomedical Catalyst for Development of Osteoporosis Treatment
11/5/2012 12:06:10 PM
More...
|
Glide Pharma Completes Oversubscribed $4.3 Million Investment Round
2/10/2010 7:09:58 AM
More...
|
Glide Pharma Secures Further £2.2 Million to Accelerate Development Programme
10/13/2008 10:33:20 AM
More...
|
Glide Pharma Secures £2.3 Million; Distribution Agreement Signed with Paladin Labs Inc. (CC:PLB)
8/15/2007 11:40:29 AM
More...
|
Paladin Labs Inc. (CC:PLB) And Glide Pharma Sign Exclusive Agreement for Novel Needle-Free Drug Delivery System
8/10/2007 8:30:52 AM
More...
|
Glide Pharma is Overall Winner of Prestigious 2007 Medical Futures Innovation Awards
6/18/2007 6:38:59 PM
More...
|